相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
T. K. Choueiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Multidrug resistance protein 4 (MRP4/ABCC4) is overexpressed in clear cell renal cell carcinoma (ccRCC) and is essential to regulate cell proliferation
Juan Pablo Melana Colavita et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
A. Sahores et al.
SCIENTIFIC REPORTS (2020)
Sunitinib induces early histomolecular changes in a subset of renal cancer cells that contribute to resistance
Zsuzsanna Lichner et al.
FASEB JOURNAL (2019)
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Georg A. Bjarnason et al.
EUROPEAN JOURNAL OF CANCER (2019)
CADM1 is a TWIST1-regulated suppressor of invasion and survival
Edward J. Hartsough et al.
CELL DEATH & DISEASE (2019)
Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis
Henriett Butz et al.
ONCOTARGET (2018)
Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry
Hiroto Hatakeyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands
Maria Jose Carlini et al.
BMC CANCER (2018)
Sunitinib in Patients With Metastatic Renal Cell Carcinoma: Clinical Outcome According to International Metastatic Renal Cell Carcinoma Database Consortium Risk Group
Brian Rini et al.
CLINICAL GENITOURINARY CANCER (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1
Mohammad Khusni B. Ahmat Amin et al.
ONCOGENE (2018)
Epidemiology profile of renal cell carcinoma: A 10-year patients' experience at King Abdulaziz Medical City, National Guard Health Affairs, Saudi Arabia
Sarah Z. Mahasin et al.
UROLOGY ANNALS (2018)
Renal Cell Tumors: Understanding Their Molecular Pathological Epidemiology and the 2016 WHO Classification
Kentaro Inamura
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer
Rebecca Swan et al.
ONCOTARGET (2016)
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis
S. Bracarda et al.
ANNALS OF ONCOLOGY (2015)
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma
Heba W. Z. Khella et al.
MOLECULAR THERAPY (2015)
miR-17 inhibition enhances the formation of kidney cancer spheres with stem cell/tumor initiating cell properties
Zsuzsanna Lichner et al.
ONCOTARGET (2015)
CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis
Qiang Ding et al.
MOLECULAR CANCER (2014)
Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy
Sonshin Takao et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature
Youssef M. Youssef et al.
EUROPEAN UROLOGY (2011)
Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
Hans J. Hammers et al.
MOLECULAR CANCER THERAPEUTICS (2010)
From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma
Androu Arsanious et al.
MOLECULAR CANCER (2009)
Activity of SU 11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma and various other solid tumors
Aristidis Polyzos
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
AC133 antigen, CD133, prominin-1, prominin-2, etc.: Prominin family gene products in need of a rational nomenclature
CA Fargeas et al.
STEM CELLS (2003)
分享论文
